Gynoflor

Gynoflor is a vaginal formulation that combines the estrogen estriol with lyophilized Lactobacillus acidophilus. It is marketed in the European Union and is intended for local application in the vagina. The product delivers a low‑dose estrogen together with probiotic bacteria to support the natural vaginal environment without systemic hormone exposure.

Gynoflor is used to address several gynecological conditions related to estrogen deficiency and vaginal microbiota imbalance. It is commonly prescribed for:

- Relief of vaginal dryness, itching, and burning associated with menopause. - Management of mild atrophic vaginitis. - Restoration of normal vaginal flora after antibiotic therapy. - Adjunct therapy following treatment of bacterial vaginosis. - Support of vaginal health in women using low‑dose estrogen therapy.

Side effects of Gynoflor are generally mild and related to local irritation, but rare serious reactions can occur.

Common: - Mild vaginal irritation or burning. - Spotting or light vaginal bleeding. - Increased vaginal discharge. - Temporary itching or discomfort.

Serious: - Allergic reaction such as rash, swelling, or hives. - Severe vaginal pain or ulceration. - Persistent abnormal bleeding. - Signs of infection like fever or foul odor.

Before using Gynoflor, consider the following precautions to ensure safe use:

- Confirm that you are not pregnant or planning pregnancy, as estrogen exposure may affect fetal development. - Discuss any history of hormone‑dependent cancers (e.g., breast, ovarian) with your healthcare provider. - Inform your clinician about existing vaginal infections or unexplained bleeding. - Use the product only as directed; avoid prolonged use without medical supervision. - Report any persistent irritation, bleeding, or allergic symptoms promptly. - Store at room temperature away from moisture and direct sunlight.

Gynoflor may interact with other medications or products applied vaginally. Consider the following guidance:

Avoid: - Concurrent use of other estrogen‑containing vaginal products, which may increase systemic absorption. - Vaginal antiseptics or spermicides that could disrupt the probiotic component.

Use with caution: - Systemic hormone therapies (e.g., oral contraceptives, hormone replacement) – monitor for additive estrogen effects. - Antifungal or antibacterial vaginal treatments – coordinate timing to preserve probiotic viability. - Immunosuppressive drugs – assess risk of infection when using probiotic preparations.